Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder
Stopped early
Conditions studied: Pediatric ADHD
In brief
The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential pediatric subjects for appropriate ADHD clinical research studies.
Key facts
- Study ID
- NCT00592436
- Run by
- Massachusetts General Hospital
- People needed
- 663
- Starts
- 2003-03-01
- Expected to finish
- 2015-05-01
- Last updated by the study team
- 2015-05-06
Who can join
Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males and females ages 6-17
- Family/guardian contacting the Clinical Research Program in Pediatric Psychopharmacology, with concerns regarding ADHD symptoms in his/her child
You may not qualify if…
- History of significant head trauma with loss of consciousness, organic brain disorders, seizures, or neurological intervention
- Any significant medical condition, in the judgment of the investigator
- Mental retardation
- Pregnancy or lactation
- Subjects with current, uncontrolled (within the past 3 months) illicit drug or alcohol dependence
- Sensory difficulties such as deafness or blindness
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.